Location History:
- Osaka, JP (2021)
- Suita, JP (2021)
Company Filing History:
3 out of 989 
1 out of 45 
1 out of 35 Years Active: 2021
Title: Masuo Kondoh: Innovator in Monoclonal Antibody Research
Introduction
Masuo Kondoh is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of monoclonal antibodies, with a focus on specific proteins that play crucial roles in cellular functions. His innovative work has led to the development of several patents that advance medical research and therapeutic applications.
Latest Patents
Masuo Kondoh holds 3 patents that highlight his expertise in monoclonal antibody technology. One of his latest patents is for an anti-claudin-2 monoclonal antibody. This invention aims to provide a monoclonal antibody that recognizes an extracellular region of Claudin-2, which is essential for understanding its role in various diseases. Another significant patent is for an anti-CLDN-5 antibody, which offers a novel molecule with high specificity to CLDN-5. This antibody recognizes an extracellular domain of the Claudin-5 protein, contributing to advancements in targeted therapies.
Career Highlights
Throughout his career, Masuo Kondoh has been associated with esteemed institutions such as Osaka University and Ehime University. His work in these universities has allowed him to collaborate with other researchers and contribute to groundbreaking studies in the field of immunology and molecular biology.
Collaborations
Masuo Kondoh has worked alongside notable colleagues, including Kiyohito Yagi and Takefumi Doi. Their collaborative efforts have further enriched the research landscape and fostered innovation in monoclonal antibody development.
Conclusion
Masuo Kondoh's contributions to monoclonal antibody research exemplify the impact of innovative thinking in the medical field. His patents and collaborations continue to pave the way for advancements in therapeutic solutions.